[Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab].
Rinsho Ketsueki
; 64(4): 265-270, 2023.
Article
in Ja
| MEDLINE
| ID: mdl-37121770
Full text:
1
Database:
MEDLINE
Main subject:
Thrombocytopenia
/
Castleman Disease
Type of study:
Diagnostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
Ja
Journal:
Rinsho Ketsueki
Year:
2023
Type:
Article